Skip to main content

Table 1 Sociodemographic and background information

From: A cross-sectional study on pelvic floor symptoms in women living with Female Genital Mutilation/Cutting

Variable n (%)
Age (years) 31.5 ± 7.5 (range = 19–54)
BMI 24.59 ± 5.37 (range = 15.2–39.0)
  < 18.5 (underweight) 10 (8.0)
 18.5–24.9 (normal weight) 68 (54.8)
 25.0–29.9 (overweight) 23 (18.6)
  ≥ 30.0 (obesity) 23 (18.6)
Time spent in Switzerland 6.4 ± 7.4 years (range = 13 days–30 years)
  < 1 year 28 (22.5)
 1–2 years 18 (14.5)
 2–3 years 11 (8.9)
 3–4 years 10 (8.1)
 4–5 years 10 (8.1)
  > 5 years 47 (37.9)
Pregnancy at the time of the study 43 (34.7)
 1st trimester 4 (9.3)
 2nd trimester 23 (53.5)
 3rd trimester 16 (37.2)
Type of FGM/C  
 Type I 9 (7.2)
 Type II 41 (33.1)
 Type III, defibulated 40 (32.3)
 Type III, infibulated 34 (27.4)
Age at FGM/C  
  < 1 year old 35 (28.2)
 1–5 years old 16 (12.9)
 6–10 years old 40 (32.3)
  > 10 years old 11 (8.9)
 Unknown 22 (17.7)
Previous defibulation (ntot = 74)  
 Yes, in labour 23 (31.1)
 Yes, during pregnancy 5 (6.8)
 Yes, outside pregnancy 13 (17.6)
 No 32 (43.2)
 Unknown 1 (1.3)
Previous reinfibulation (ntot = 42)  
 No 35 (83.3)
 Yes 6 (14.3)
 Unknown 1 (2.4)
Past violent events  
 Physical 5 (4.0)
 Psychological 10 (8.1)
 Sexual 4 (3.2)
 Several (psychological/physical/sexual) 37 (29.9)
 None 64 (51.6)
 No answer 4 (3.2)
Delivery (ntot = 78)  
 Vaginal 58 (74.4)
 Cesarean section 20 (25.6)
Pelvic organ prolapse4  
 No 122 (98.4)
 Yes 2 (1.6)
  1. 1Acute complications: hemorrhage, pain, urinary pain, infection
  2. 2Chronic complications: menstrual, sexual, urinary, scarring, obstetric
  3. 3Other ethnic origin: Burkina Faso, Chad, Djibouti, Gambia, Guinea, Guinea-Bissau, Ivory Coast, Mali, Nigeria, Senegal, Sierra Leone, Sudan, Togo
  4. 4Prolapsus stage POP- + : 1 (n = 1), 2 (n = 1)